home / stock / silo / silo articles


SILO Articles, SILO Pharma Inc

Stock Information

Company Name: SILO Pharma Inc
Stock Symbol: SILO
Market: OTC
Website: silopharma.com

Menu

SILO SILO Quote SILO Short SILO News SILO Articles SILO Message Board
Get SILO Alerts

News, Short Squeeze, Breakout and More Instantly...

Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.33% to 38,840.06 ...

Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Lands’ End, Inc. (NASDAQ:LE) fell sharply during Wednesday's session following first-quarter results. Lands’ End reporte...

Gold Gains 1%; ISM Services PMI Surges In May | Benzinga

U.S. stocks traded higher midway through trading, with the Nasdaq Composite surging over 1% on Wednesday. The Dow traded up 0.04% to 38,728.39 whil...

Why Silo Pharma Stock Is Down Over 30% | Benzinga

Silo Pharma Inc (NASDAQ:SILO) shares are trading lower by 31% to $1.55 during Wednesday’s session after the company announced it has entered ...

Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine | Benzinga

SARASOTA, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutica...

Citizens And 2 Other Stocks Under $3 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern aro...

Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern arou...

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More | Benzinga

Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024. See prev...

Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic | Benzinga

Exclusive license for development, manufacturing, and commercialization in process Silo Pharma to file Pre-IND in first half 2024 SARASOTA, FL, Ma...

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More | Benzinga

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned ...

Next 10